Kristin Highland, MD, and Ryan Haumschild, PharmD, MS, MBA, compare management tools to self-regulation for the best ILD treatment outcome, as well as patient access to nintedanib, pirfenidone, and ...

Please provide your email address to receive an email when new articles are posted on . In this Healio Video Perspective from the AWIR Annual Conference, Janet Pope, MD, professor of medicine, ...

Please provide your email address to receive an email when new articles are posted on . “Overall, this was a pretty provocative study,” Sparks, an associate professor of medicine at Harvard Medical ...

The prevalence of interstitial lung disease (ILD) across connective tissue disorders (CTDs) and its persistent standing as a leading cause of death in patients with CTDs challenge rheumatologists to ...